Not cancer · Austria
Alzheimer disease
How is it diagnosed today? There is no simple, reliable test. The doctor checks your general health, may order blood tests and ask about your medicines to rule out other causes, and asks you to do some memory and thinking tasks. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.5 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Symptom medicines (e.g. donepezil) plus support. NHS
5 medicines are approved for this disease in Austria:
- Donanemab (Kisunla) – approved in 2025
- Lecanemab (Leqembi) – approved in 2025
- Memantine (Memantine Mylan, Memantine ratiopharm, memantine hydrochloride) – approved in 2013
- Memantine hydrochloride (Memantine Merz) – approved in 2012
- Rivastigmine (Rivastigmine, Exelon, Exelon Patch) – approved in 2009
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (7)
- Benzgalantamine (Zunveyl) – approved for it in the US
- Brexpiprazole (Rexulti) – approved for it in the US
- Dextromethorphan and bupropion (Auvelity) – approved for it in the US
- Donepezil (Aricept, Donepezil Sandoz) – approved for it in the US, Switzerland, and France
- Galantamine (Galantamine, Reminyl PR, Galantamine Biogaran Lp) – approved for it in the US, Switzerland, and France
- Memantine and donepezil (Namzaric) – approved for it in the US
- Risperidone (Risperdal, Risperidone Eg) – approved for it in France
Being tested in people
5 open trials in Austria, 624 worldwide. See the trials
- ACP-204 (Phase 3)
- AR1001 (Phase 3)
- Atomoxetine (Phase 3)
- buntanetap/posiphen (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 3 were in animals and 0 in the lab. See them
No proof it works
We checked 13 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Mistletoe extract (only single reports in people)
- Hyperthermia (animal studies only)
- Ivermectin (animal studies only)
- Dichloroacetate (DCA) (lab studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
3 open trials in Austria with these filters
Tests NSC001 for safety in mild to moderate Alzheimer's disease
NCT06995573 · ClinicalTrials.gov
- Graz – University Hospital Graz
- Innsbruck – Medizinische Universitaet Innsbruck
- Salzburg – Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH
Ages 50 to 85
Contact the trial teamScanning a Transport Protein in Healthy Adults and Alzheimer's Patients
2024-517851-11-00 · EU Clinical Trials Register
- Vienna – Medical University of Vienna
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudying how a brain scan tracer moves in healthy adults and people with Alzheimer's
2024-517875-19-00 · EU Clinical Trials Register
- Vienna – Medical University of Vienna
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
Available abroad (88 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Tests ALN-5288 injected into the spinal fluid for Alzheimer's disease
NCT07214727 · ClinicalTrials.gov
Countries: Spain, United Kingdom, Netherlands and 1 more
- Barcelona, Spain – Hospital Clinic de Barcelona
- Madrid, Spain – Hospital Clínico San Carlos
- Sant Cugat del Vallès, Spain – Hospital Universitari General de Catalunya
Ages 40 to 80
Contact the trial teamBrain Immuno-PET
2026-525254-10-00 · EU Clinical Trials Register
Countries: Netherlands
- Amsterdam, Netherlands – Amsterdam UMC Stichting
Age 18 and over
Contact the trial teamTests ALN-APP, an injected drug, in early-onset Alzheimer's disease
NCT05231785 · ClinicalTrials.gov
Countries: United Kingdom, Netherlands, Canada and 1 more
- Sheffield, United Kingdom – hospital not given
- Amsterdam, Netherlands – Brain Research Center Amsterdam B.V.
- Montreal, Canada – hospital not given
Age 18 and over
Contact the trial teamTests LY3954068 safety in people with early Alzheimer's disease
NCT06297590 · ClinicalTrials.gov
Countries: United Kingdom, Japan, United States
- London, United Kingdom – National Hospital for Neurology and Neurosurgery (UCLH)
- Sheffield, United Kingdom – Royal Hallamshire Hospital
- Southampton, United Kingdom – University Hospital Southampton
Ages 50 to 85
Contact the trial teamTests a new PET scan tracer for TDP-43 protein in the brain
NCT06891716 · ClinicalTrials.gov
Countries: Netherlands
- Amsterdam, Netherlands – Amsterdam UMC
Ages 40 to 70
Contact the trial teamSafety of DNL921 in Healthy Adults and People With Alzheimer's Disease
NCT07758595 · ClinicalTrials.gov
Countries: United Kingdom
- Manchester, United Kingdom – Clinical Site(s)
Ages 18 to 75
Contact the trial teamTests ACI-24.060 in early Alzheimer's disease and adults with Down syndrome
NCT05462106 · ClinicalTrials.gov
Countries: Spain, United Kingdom, United States
- Barcelona, Spain – Fundació ACE, Institut Català de Neurociències Aplicades
- Barcelona, Spain – Hospital de la Santa Creu i Sant Pau
- Granada, Spain – Hospital Universitario Virgen de las Nieves
Ages 35 to 85
Contact the trial teamTesting DNL628 for Safety in People With Early Alzheimer's Disease
NCT07328451 · ClinicalTrials.gov
Countries: United Kingdom, Netherlands
- London, United Kingdom – Clinical Site(s)
- Amsterdam, Netherlands – Brain Research Center Amsterdam B.V.
- 's-Hertogenbosch, Netherlands – Brain Research Center Den Bosch B.V.
Ages 18 to 75
Contact the trial teamStem Cells From Donated Fat Tissue for Mild to Moderate Alzheimer Disease
NCT07367815 · ClinicalTrials.gov
Countries: France
- Toulouse, France – Centre Hospitalier Universitaire de Toulouse
Ages 50 to 85
Contact the trial teamTests etanercept with repeated ultrasound in people with Alzheimer's disease
2023-505714-19-00 · EU Clinical Trials Register
Countries: France
- Paris, France – Hopital Fondation Adolphe de Rothschild
Age 18 and over
Contact the trial teamTests etanercept with ultrasound to open the brain barrier in Alzheimer's
NCT06585384 · ClinicalTrials.gov
Countries: France
- Paris, France – Fondation Adolphe de Rothschld
Ages 50 to 85
Contact the trial teamTests stool bacteria transplant in people with Alzheimer's disease
NCT07332260 · ClinicalTrials.gov
Countries: Norway
- Tromsø, Norway – University Hospital of North Norway, Tromsø
Age 18 and over
Contact the trial teamBrain imaging of alpha-7 nicotinic receptors in Alzheimer's disease and mild cognitive impairment
2024-515935-31-04 · EU Clinical Trials Register
Countries: Sweden
- Huddinge, Sweden – Karolinska Institutet
- Solna, Sweden – Karolinska Institutet
- Solna, Sweden – CTC Clinical Trial Consultants AB
Age 18 and over
Contact the trial teamTests efavirenz in adults with early Alzheimer's disease
2023-509613-37-01 · EU Clinical Trials Register
Countries: Netherlands
- Amsterdam, Netherlands – Brain Research Center Amsterdam B.V.
Age 18 and over
Contact the trial teamBrain scan tracer to measure Hsp90 in healthy adults and neurodegenerative disease
NCT07380204 · ClinicalTrials.gov
Countries: Belgium
- Leuven, Belgium – UZ Leuven
Ages 18 to 70
Contact the trial teamTests NIO752 for lowering tau protein production in Alzheimer disease
NCT06372821 · ClinicalTrials.gov
Countries: United Kingdom, United States
- London, United Kingdom – University College London Hospitals NHS Foundation Trust
- St Louis, United States – Washington University in St. Louis
Ages 21 to 80
Contact the trial teamTests a probiotic capsule in older adults with mild Alzheimer's disease
NCT06181513 · ClinicalTrials.gov
Countries: Cyprus
- Nicosia, Cyprus – The Cyprus Institute of Neurology and Genetics
Ages 65 to 85
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamEarly safety study of LY4560736 in healthy adults and people with Alzheimer's disease
NCT07843459 · ClinicalTrials.gov
Countries: China, Japan, United States
- Beijing, China – Peking University Third Hospital
- Beijing, China – Xuanwu Hospital, Capital Medical University
- Shanghai, China – Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Ages 18 to 85
Contact the trial teamPET Imaging of PDE4 Enzyme in Alzheimer Disease and Mild Cognitive Impairment
NCT07169630 · ClinicalTrials.gov
Countries: United States
- Bethesda, United States – National Institutes of Health Clinical Center
Ages 50 to 100
Contact the trial teamLY4405094 in healthy volunteers and people with Alzheimer's disease
NCT07787182 · ClinicalTrials.gov
Countries: China, Japan, United States
- Beijing, China – Xuanwu Hospital, Capital Medical University
- Beijing, China – Peking University Third Hospital
- Shanghai, China – Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Ages 18 to 85
Contact the trial teamTests ARO-MAPT-SC against placebo in healthy adults and early Alzheimer's disease
NCT07221344 · ClinicalTrials.gov
Countries: Canada, New Zealand
- East York, Canada – hospital not given
- Montreal, Canada – hospital not given
- Toronto, Canada – hospital not given
Age 18 and over
Contact the trial teamInterleukin-2 With Semaglutide for People With Alzheimer's Disease
NCT07651319 · ClinicalTrials.gov
Countries: United States
- Houston, United States – Houston Methodist Research Institute
Ages 50 to 86
Contact the trial teamEarly safety study of LY4405094, an amyloid-targeting drug, in Alzheimer's disease
NCT07787169 · ClinicalTrials.gov
Countries: China, Japan, United States
- Beijing, China – Xuanwu Hospital, Capital Medical University
- Beijing, China – Peking University Third Hospital
- Shanghai, China – Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Ages 18 to 85
Contact the trial teamTests LY3439539 effects on spinal fluid proteins in Alzheimer's disease
NCT07598370 · ClinicalTrials.gov
Countries: Australia, New Zealand, Singapore and 1 more
- Adelaide, Australia – Flinders Medical Centre
- Ivanhoe, Australia – Austin Health - Heidelberg Repatriation Hospital
- Kogarah, Australia – Southern Neurology
Ages 50 to 85
Contact the trial teamPET Brain Scans Measure Inflammation in Neurodegenerative Diseases
NCT04396873 · ClinicalTrials.gov
Countries: United States
- Bethesda, United States – National Institutes of Health Clinical Center
Ages 18 to 99
Contact the trial teamProbiotic Supplement Safety in People at Risk of Alzheimer's Disease
NCT07413744 · ClinicalTrials.gov
Countries: United States
- Madison, United States – University of Wisconsin Hospitals and Clinics
Age 60 and over
Contact the trial teamFirst test of the tablet PF-08161842 in healthy and older adults
NCT07897708 · ClinicalTrials.gov
Ages 18 to 85
Contact the trial teamTesting increasing doses of VY1706 in people with early Alzheimer's disease
NCT07764146 · ClinicalTrials.gov
Countries: United States
- Maitland, United States – K2 Medical Research, LLC
- Orlando, United States – AdventHealth Orlando
Ages 30 to 80
Contact the trial teamLithium orotate compared with placebo in early Alzheimer's disease
NCT07459959 · ClinicalTrials.gov
No age limit given in the registry
Contact the trial teamTesting Higher Doses of Memantine in Young Adults With Down Syndrome
NCT07531940 · ClinicalTrials.gov
Countries: United States
- Cleveland, United States – University Hospitals Case Medical Center
Ages 18 to 32
Contact the trial teamTests SNK01 in people with moderate Alzheimer's disease
NCT06189963 · ClinicalTrials.gov
Countries: Canada, United States
- Ottawa, Canada – Ottawa Memory Clinic
- Albany, United States – Alzheimer's Disease Research Center
- Glendale, United States – Behavioral Research Specialists, LLC
Ages 40 to 85
Contact the trial teamTests a new Alzheimer's vaccine for safety in healthy adults
NCT07142278 · ClinicalTrials.gov
Countries: United States
- Miami Lakes, United States – Palm Springs Community Health Center
Ages 40 to 65
Contact the trial teamTesting 2-HOBA in people with early Alzheimer's disease or mild memory decline
NCT06432166 · ClinicalTrials.gov
Countries: United States
- Nashville, United States – Center for Cognitive Medicine, Vanderbilt University Medical Center
Ages 55 to 85
Contact the trial teamTests BMS-986446 in healthy adults and early Alzheimer's disease
NCT07780383 · ClinicalTrials.gov
Countries: United States
- Anaheim, United States – CenExel ACT (Formerly Anaheim Clinical Trials; LLC)
- Bradenton, United States – hospital not given
- Daytona Beach, United States – hospital not given
Ages 18 to 80
Contact the trial teamTests ABBV-1758 for safety and effects in Alzheimer's disease
NCT07599670 · ClinicalTrials.gov
Countries: China, United States
- Beijing, China – Xuanwu Hospital Capital Medical University
- Guangzhou, China – The Second Affiliated Hospital of Guangzhou Medical University
- Boulder, United States – Alpine Clinical Research Center - Boulder - 47th Street
Ages 50 to 90
Contact the trial teamTesting a fasting-mimicking diet and rapamycin in middle-aged adults with APOE 4
NCT06682767 · ClinicalTrials.gov
Countries: United States
- Los Angeles, United States – Cedars-Sinai Medical Center
Ages 45 to 65
Contact the trial teamPsilocybin and dextromethorphan in healthy older adults with low well-being
NCT07386730 · ClinicalTrials.gov
Countries: United States
- San Francisco, United States – University of California San Francisco, Sandler Neuroscience Building
Ages 50 to 85
Contact the trial teamImaging Study Using a Radiotracer to Detect Demyelination in Brain and Spinal Cord
NCT06999434 · ClinicalTrials.gov
Countries: United States
- New Haven, United States – Yale University PET Center
Ages 18 to 90
Contact the trial teamTests psilocybin for depression in people with memory decline
NCT04123314 · ClinicalTrials.gov
Countries: United States
- Baltimore, United States – Johns Hopkins Center for Psychedelic and Consciousness Research
Ages 18 to 85
Contact the trial teamLarge-coil brain stimulation to study memory in Alzheimer disease
NCT06597942 · ClinicalTrials.gov
Countries: United States
- Los Angeles, United States – UCLA TMS Clinical and Research Service
Ages 55 to 100
Contact the trial team
Showing 40 of 88. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- In animalsA Mito-CoQ10-TPP Nanocarrier Hybrid Enhances the Therapeutic Efficacy of Mitochondrial Transplantation in Alzheimer's Disease.ACS Chem Neurosci · 2026-11-18
- In animalsGalectin-3 links microglial neuroinflammation to Aβ aggregation and lysosomal processing.Proc Natl Acad Sci U S A · 2026-11-18
- In peopleThirteen-month real-world effectiveness and safety of lecanemab in Chinese patients with Alzheimer's disease: integrating objective clinical outcomes and caregiver-reported experiences.J Neurol · 2026-11-18
- ReviewDistinguishing Major Forms of Dementia Through Neuropsychological Performances: A Systematic Review With Structured Narrative Synthesis.J Geriatr Psychiatry Neurol · 2026-11-18
- In animalsAβ Aggregate-Gated Ratiometric Probe Reveals Peri-Plaque Acidification Arising from Lysosomal Dysfunction in Alzheimer's Disease.ACS Chem Neurosci · 2026-11-18
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Alzheimer Austria
Self-help organisation for 35+ years: free confidential counselling by appointment (alzheimeraustria@aon.at), young-onset group, peer counselling, partner and adult-children groups, Alzheimer Cafe, carer course.
- Demenz Selbsthilfe Austria
Federation and umbrella organisation of dementia self-help groups in Austria (founded 2021); Alzheimer Europe full member.
- Demenzstrategie „Gut leben mit Demenz“
Public portal of Austria's national dementia strategy with material for people with dementia and relatives and links to regional services.
- Fonds Demenzhilfe Österreich (Volkshilfe Demenzhilfe)
Volkshilfe initiative giving financial aid to people with dementia at risk of poverty; information on counselling, self-help groups and care services.
- MAS Alzheimerhilfe
Dementia service points (information and practical help for people with dementia and relatives), guided self-help groups, Alzheimer holiday for couples, carer tips.
Phone: +43 6132 214 10
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (9)
- Alzheimer Europe
Umbrella of national Alzheimer associations in 39 countries, with a member directory.
- Alzheimer's Association
Free 24/7 Helpline (interpreters for 200+ languages), care consultations with dementia experts, local chapters, Community Resource Finder, ALZConnected online community.
- Alzheimer's Disease International (ADI)
Global federation of dementia associations in 100+ countries: member associations list, find local support, dementia information, World Alzheimer Report.
- Alzheimer's Drug Discovery Foundation
Funds the early work on new Alzheimer's medicines, in universities and companies.
Phone: 212.901.8000
- BrightFocus Foundation
US nonprofit that funds research and provides public information on Alzheimer's disease, macular degeneration and glaucoma.
- Dementia Alliance International (DAI)
Organisation for people with a dementia diagnosis: free online peer support groups, webinars, Brain Health Hub, resources for care partners.
- European Federation of Neurological Associations (EFNA)
Umbrella of 21 pan-European neurology patient groups; map of European neurology patient organisations.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Not medical advice. We show what is open and what is known; your care team decides what fits you.